Tag Archives: Doctors must keep Ozempic prescriptions in check

Doctors in Denmark should limit how many packs of Novo Nordisk’s Ozempic diabetes drug patients can pick up at one time, the Danish Patient Safety Authority said on Monday, amid worries that some may acquire a larger supply than needed. Neighbouring Norway meanwhile said it would tighten restrictions on the use of Ozempic, requiring doctors to seek cost reimbursements on …

Read More »